HighMark Wealth Management’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$215K Hold
55,878
0.07% 80
2026
Q1
$221K Hold
55,878
0.09% 72
2025
Q4
$378K Hold
55,878
0.15% 57
2025
Q3
$390K Buy
55,878
+2,878
+5% +$20K 0.17% 55
2025
Q2
$324K Buy
53,000
+10,000
+23% +$66.5K 0.16% 58
2025
Q1
$327K Buy
43,000
+40,000
+1,333% +$334K 0.19% 41
2024
Q4
$28.9K Hold
3,000
0.02% 171
2024
Q3
$17.7K Hold
3,000
0.01% 217
2024
Q2
$20.8K Buy
+3,000
New +$21.1K 0.01% 199

Other funds holding MDXG

HighMark Wealth Management's MDXG Position: Q2 2026 in Review

HighMark Wealth Management held its MiMedx Group (MDXG) position steady in Q2 2026 at 55,878 shares worth $215K. The position accounts for 0.07% of the portfolio, ranked #80.

HighMark Wealth Management first reported a position in MDXG in Q2 2024 and has held it in 9 quarters since. The position peaked at $390K in Q3 2025. 226 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • HighMark Wealth Management held 55,878 shares of MiMedx Group worth $215K as of Q2 2026.
  • HighMark Wealth Management left its MiMedx Group share count unchanged in Q2 2026.
  • MiMedx Group made up 0.07% of HighMark Wealth Management's portfolio in Q2 2026, its #80 holding.
  • HighMark Wealth Management first reported a position in MiMedx Group in Q2 2024 and has held it in 9 quarters since.
  • HighMark Wealth Management's MiMedx Group position peaked at $390K in Q3 2025.
  • 226 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.